Western University

Scholarship@Western
Paediatrics Publications

Paediatrics Department

1-9-2017

Nerve Growth Factor Promotes Gastric Tumorigenesis through
Aberrant Cholinergic Signaling
Yoku Hayakawa
Columbia University Irving Medical Center

Kosuke Sakitani
Columbia University Irving Medical Center

Mitsuru Konishi
Graduate School of Medicine

Samuel Asfaha
Columbia University Irving Medical Center, samuel.asfaha@lhsc.on.ca

Ryota Niikura
Graduate School of Medicine

See next page for additional authors

Follow this and additional works at: https://ir.lib.uwo.ca/paedpub

Citation of this paper:
Hayakawa, Yoku; Sakitani, Kosuke; Konishi, Mitsuru; Asfaha, Samuel; Niikura, Ryota; Tomita, Hiroyuki;
Renz, Bernhard W.; Tailor, Yagnesh; Macchini, Marina; Middelhoff, Moritz; Jiang, Zhengyu; Tanaka,
Takayuki; Dubeykovskaya, Zinaida A.; Kim, Woosook; Chen, Xiaowei; Urbanska, Aleksandra M.; Nagar,
Karan; Westphalen, Christoph B.; Quante, Michael; Lin, Chyuan Sheng; Gershon, Michael D.; Hara, Akira;
Zhao, Chun Mei; Chen, Duan; Worthley, Daniel L.; Koike, Kazuhiko; and Wang, Timothy C., "Nerve Growth
Factor Promotes Gastric Tumorigenesis through Aberrant Cholinergic Signaling" (2017). Paediatrics
Publications. 699.
https://ir.lib.uwo.ca/paedpub/699

Authors
Yoku Hayakawa, Kosuke Sakitani, Mitsuru Konishi, Samuel Asfaha, Ryota Niikura, Hiroyuki Tomita,
Bernhard W. Renz, Yagnesh Tailor, Marina Macchini, Moritz Middelhoff, Zhengyu Jiang, Takayuki Tanaka,
Zinaida A. Dubeykovskaya, Woosook Kim, Xiaowei Chen, Aleksandra M. Urbanska, Karan Nagar, Christoph
B. Westphalen, Michael Quante, Chyuan Sheng Lin, Michael D. Gershon, Akira Hara, Chun Mei Zhao, Duan
Chen, Daniel L. Worthley, Kazuhiko Koike, and Timothy C. Wang

This article is available at Scholarship@Western: https://ir.lib.uwo.ca/paedpub/699

Article

Nerve Growth Factor Promotes Gastric
Tumorigenesis through Aberrant Cholinergic
Signaling
Graphical Abstract

Authors
Yoku Hayakawa, Kosuke Sakitani,
Mitsuru Konishi, ..., Daniel L. Worthley,
Kazuhiko Koike, Timothy C. Wang

Correspondence
tcw21@columbia.edu

In Brief
Hayakawa et al. use a series of mouse
models to show that acetylcholine from
Dclk1+ tuft cells and nerves induces NGF
in gastric epithelial cells, which promotes
neuron expansion and tumorigenesis.
YAP is activated through the cholinergic
signaling, and inhibition of this pathway
can block NGF-driven tumors.

Highlights
d

NGF expression is induced in gastric cancer by ACh from
nerves and tuft cells

d

NGF promotes innervation and proliferation in gastric
epithelium

d

Blockade of NGF or ablation of cholinergic tuft cells inhibits
tumor development

d

Cholinergic signaling activates YAP signaling that is essential
for Wnt activation

Hayakawa et al., 2017, Cancer Cell 31, 21–34
January 9, 2017 ª 2017 Elsevier Inc.
http://dx.doi.org/10.1016/j.ccell.2016.11.005

Accession Numbers
GSE30295

Cancer Cell

Article
Nerve Growth Factor Promotes Gastric Tumorigenesis
through Aberrant Cholinergic Signaling
Yoku Hayakawa,1,2,12 Kosuke Sakitani,1,12 Mitsuru Konishi,2 Samuel Asfaha,1,3 Ryota Niikura,2 Hiroyuki Tomita,4
Bernhard W. Renz,1,5 Yagnesh Tailor,1 Marina Macchini,1 Moritz Middelhoff,1 Zhengyu Jiang,1 Takayuki Tanaka,1
Zinaida A. Dubeykovskaya,1 Woosook Kim,1 Xiaowei Chen,1 Aleksandra M. Urbanska,1 Karan Nagar,1
Christoph B. Westphalen,1,6 Michael Quante,7 Chyuan-Sheng Lin,8,9 Michael D. Gershon,8 Akira Hara,4 Chun-Mei Zhao,10
Duan Chen,10 Daniel L. Worthley,1,11 Kazuhiko Koike,2 and Timothy C. Wang1,13,*
1Division of Digestive and Liver Diseases, Department of Medicine, Irving Cancer Research Center, Columbia University Medical Center,
1130 Street Nicholas Avenue, New York, NY 10032-3802, USA
2Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo 1138655, Japan
3Department of Medicine, University of Western Ontario, London, ON N6A 5W9, Canada
4Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu 5011194, Japan
5Department of General, Visceral, Transplantation, Vascular and Thoracic Surgery, Hospital of the University of Munich, Munich 81377,
Germany
6Department of Internal Medicine III, Klinikum der Universita
€t Mu
€ nchen, Munich 81377, Germany
7Department of Internal Medicine II, Klinikum rechts der Isar, II. Technische Universita
€t Mu
€ nchen, Munich 81675, Germany
8Department of Pathology and Cell Biology
9Transgenic Mouse Shared Resource
Columbia University, New York, NY 10032, USA
10Department of Cancer Research and Molecular Medicine, NTNU - Norwegian University of Science and Technology, Trondheim 7491,
Norway
11Cancer Theme, SAHMRI and Department of Medicine, University of Adelaide, SA 5000, Australia
12Co-first author
13Lead Contact
*Correspondence: tcw21@columbia.edu
http://dx.doi.org/10.1016/j.ccell.2016.11.005

SUMMARY

Within the gastrointestinal stem cell niche, nerves help to regulate both normal and neoplastic stem cell dynamics. Here, we reveal the mechanisms underlying the cancer-nerve partnership. We find that Dclk1+ tuft
cells and nerves are the main sources of acetylcholine (ACh) within the gastric mucosa. Cholinergic stimulation of the gastric epithelium induced nerve growth factor (NGF) expression, and in turn NGF overexpression
within gastric epithelium expanded enteric nerves and promoted carcinogenesis. Ablation of Dclk1+ cells or
blockade of NGF/Trk signaling inhibited epithelial proliferation and tumorigenesis in an ACh muscarinic
receptor-3 (M3R)-dependent manner, in part through suppression of yes-associated protein (YAP) function.
This feedforward ACh-NGF axis activates the gastric cancer niche and offers a compelling target for tumor
treatment and prevention.

INTRODUCTION
There has been considerable interest in the biologic and therapeutic implications of neural regulation of normal stem cells and
cancer growth (Brownell et al., 2011; Hanoun et al., 2014; Katayama et al., 2006; Magnon et al., 2013; Mendez-Ferrer et al.,
2010; Peterson et al., 2015; Stopczynski et al., 2014; Venkatesh

et al., 2015; Zhao et al., 2014). In the gastrointestinal tract, acetylcholine (ACh) regulates epithelial stem cells, proliferation, and
tumorigenesis via the muscarinic receptor-3 (M3R), in part
through modulation of Wnt signaling (Lundgren et al., 2011;
Raufman et al., 2008; Zhao et al., 2014). Canonical Wnt activation
is characterized by nuclear translocation of b-catenin leading to
activation of the transcriptional factor T cell factor (TCF) family

Significance
The factors driving nerve expansion during tumorigenesis and the downstream targets of nerve signaling are not well understood. This study investigates the extensive crosstalk that occurs during carcinogenesis between cancer cells and
nerves, and identifies the ACh-NGF-M3R-YAP axis that is central to gastric cancer biology. This work proposes potential
targets for cancer therapy, such as NGF and M3R, which can be clinically applied in the near future.
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and target gene expression. However, to achieve TCF activation,
multiple transcriptional co-activators are required, including the
yes-associated protein (YAP) (Rosenbluh et al., 2012), which
appears to form an important part of the ACh-M3R axis.
Although many cancers, including stomach, pancreas, and
colon, show increased nerve density (Albo et al., 2011; Ceyhan
et al., 2010; Zhao et al., 2014), the overall significance of
tumor-associated neural plasticity remains uncertain. The neurotrophin family molecules signal through Trk receptors to support
neuron survival and axonal growth. In cancer, there is often an
upregulation of neurotrophins or Trk receptors to activate cancer
cell proliferation in an autocrine manner (Dolle et al., 2004;
Weeraratna et al., 2001). Trk inhibitors that suppress neurotrophin signaling have been used in the treatment of cancers characterized by an activated Trk fusion protein (Vaishnavi et al.,
2015). Given the relevance of neurotrophin/Trk signaling in neural development, and the possible importance of this pathway
in cancer signaling, we hypothesized that neurotrophin/Trk
signaling might represent a potent driver of peritumoral innervation and tumor growth.
The enteric nervous system (ENS) has an ability to regulate
gastrointestinal homeostasis through direct innervations to
gastrointestinal crypts (Gross et al., 2012; Neal and Bornstein,
2007), which appears to be linked to epithelial homeostasis.
For example, sympathetic nerves accelerate crypt cell proliferation through norepinephrine (Tutton and Helme, 1973), and
serotonin from ENS components promotes growth and turnover
of the mucosal epithelium, by regulating muscarinic cholinergic
innervation to epithelial effectors (Gross et al., 2012; Tutton
and Barkla, 1986). Although the role of cholinergic signaling in
gut proliferation and cancer has been suggested, the precise
molecular mechanism in the ENS-cancer interaction remains
uncertain.
Nerves also promote mucosal regeneration indirectly via
Dclk1+ tuft cells. Dclk1+ tuft cells act, in part, as intermediary
niche cells coordinating neural input to help regulate subsequent
stem cell activity (Chandrakesan et al., 2015; Westphalen et al.,
2014). Tuft cells express choline-acetyltransferase (ChAT), the
enzyme responsible for ACh production, and they have a
neuron-like gene expression signature (Schutz et al., 2015).
Tuft cells also express cytokines such as interleukin-25 and cyclooxygenase-2, and help to mediate inflammatory responses
within gastrointestinal mucosa (Bezencon et al., 2008; von
Moltke et al., 2016). Given their unique nature, we hypothesized
that tuft cells are well placed to help coordinate the crosstalk
between nerves and cancer. Accordingly, we conducted this
study to reveal the whole picture of the nerve-cancer interaction
during tumorigenesis with multiple mouse models.
RESULTS
ChAT+ Tuft Cells and Nerves Expand within Gastric
Mucosa during Tumorigenesis
We first explored the source of ACh within the alimentary tract
using Chat-GFP transgenic mice, in which all ACh-producing
cells are GFP+ (Tallini et al., 2006). Chat-GFP is expressed in
nerve fibers within the lamina propria and the submucosal and
myenteric ganglia (Figures 1A and S1A). GFP+ nerve fibers surround the base of glands, where stem cells such as Lgr5+ cells
22 Cancer Cell 31, 21–34, January 9, 2017

reside, supporting the notion that cholinergic nerves contribute
to the gastrointestinal stem cell niche through close physiological contact (Figures 1B, S1B, and S1C). As shown previously
(Schutz et al., 2015), Chat-GFP is also expressed in epithelial
tuft cells that are positive for Dclk1 (Figures 1A and S1A). Immunostaining revealed that Dclk1 is strongly expressed in tuft
cells, but also detected mild-to-moderate Dclk1 expression in
Chat-GFP+ cholinergic nerve fibers and ganglia (Figures 1A,
1B, and S1A). Our Dclk1-CreERT mice (Westphalen et al.,
2014) confirmed Dclk1 expression in a subset of ENS as well
as epithelial tuft cells, and both of which showed immunopositivity for ACh (Figures S1D and S1E). However, Dclk1 is not
expressed in other stromal lineages, such as a-smooth muscle
actin (SMA)+ myofibroblasts, CD31+ endothelial cells, CD45+
hematopoietic cells, or NG2+ pericytes (Figure S1F). Taken
together, these results suggest that expression of Dclk1 identifies most, if not all, cholinergic signaling cells within the gut,
including both epithelial tuft cells and stromal neurons.
We reported previously that Lgr5+ gastric stem cells express
high levels of M3R and expand in response to cholinergic
signaling during carcinogenesis (Zhao et al., 2014). Interestingly,
in an N-nitroso-N-methylurea (MNU) carcinogen mouse model of
gastric cancer, we found a dynamic relationship between epithelium and stroma in terms of cholinergic cell distribution during
tumor development. Early in the model (first 3 months after
MNU treatment), there was a significant increase in Chat-GFP+
tuft cells in the epithelium. But, after 9 months, there was a
gradual loss of epithelial Chat-GFP+ tuft cells, accompanied by
axonogenesis of cholinergic nerve fibers (Figures 1C–1E).
Thus, the early expansion of Chat+ tuft cells during carcinogenesis, followed by the later increase in cholinergic innervation
with progression to dysplasia, suggests a requirement for
ACh production in tumorigenesis from different sources, depending on tumor stage.
ACh Signaling Stimulates NGF Production in Gastric
Epithelial Cells
Cholinergic stimulation has been shown to induce the expression of certain neurotrophin family molecules (da Penha Berzaghi
et al., 1993; Lapchak et al., 1993; Mahmoud et al., 2015). In support of these observations, treatment of gastric organoids with
the cholinergic agonist carbachol upregulated the expression
of Ngf in an M3R-dependent fashion (Figure 2A). Of all the major
neurotrophins (nerve growth factor [NGF], brain-derived neurotrophic factor, neurotrophin 3, neurotrophin 4, and glial cell
line-derived neurotrophic factor), NGF was most highly and specifically upregulated by carbachol (Figures 2A and S2A). In
mouse gastric tumors, there was also a specific upregulation
of Ngf (almost 20 times higher expression than the normal stomach), and such upregulation was not observed in any other neurotrophins (Figure 2B). Similar upregulation of Ngf was found in
mouse colorectal tumors induced by azoxymethane (AOM) and
dextran sodium sulfate (DSS) (Figure S2B). Interestingly, abrogation of cholinergic signaling in the stomach by surgical vagotomy
was able to inhibit Ngf upregulation in gastric tumors (Figure 2C).
Immunostaining and in situ hybridization confirmed that NGF
was expressed within the neoplastic epithelium rather than the
stromal compartment (Figures 2D and S2C), a finding confirmed
by cell sorting and subsequent qPCR (Figures 2E and 2F).

Figure 1. ChAT+ Tuft Cells and Nerves Expand during Carcinogenesis
(A) Dclk1 staining (red) in Chat-GFP (green) mice antrum. Blue arrow indicates tuft cells, and yellow arrow indicates nerves.
(B) Left, Peripherin staining (red) in Chat-GFP mice antrum. Arrows indicate GFP+ nerves. Right, Dclk1 staining (red) in Lgr5-GFP mice antrum.
(C) Chat-GFP expression with or without MNU treatment (3 and 9 months after the beginning of MNU).
(D) The number of ChAT+ epithelial cells per gland in MNU-treated or untreated stomachs. A total of 100 glands per group were analyzed.
(E) Cell position of ChAT+ stromal cells in MNU-treated or untreated stomachs. A total of 50 glands per group was analyzed.
Means ± SEM. *p < 0.05 (ANOVA). DAPI, blue. Scale bars, 20 mm. See also Figure S1.

MNU tumor-derived organoids that are cultured in isolation,
separated from their native microenvironment, lost Ngf expression within 7 days. However, treatment with the ACh mimetic
carbachol partly reestablished Ngf upregulation (Figure S2D).
Therefore, ACh production, possibly from tuft cells initially but
later from innervated nerves with axonogenesis, is at least partly
responsible for the neoplastic upregulation of NGF.
NGF/Trk Signaling Regulates Mucosal Innervation
Based on our hypothesis that NGF plays a role in tumor-associated innervation, we generated knockin mice which conditionally

express mouse Ngf gene to test this in vivo. To create this
line, a Lox-STOP-Lox-Ngf-IRES-GFP construct was inserted
into the Rosa26 (referred to as R26) gene locus (Figure 3A). To
target NGF expression to the gastric epithelium, we used a
Tff2-BAC-Cre line (Dubeykovskaya et al., 2016), which targeted
Cre recombinase expression to the entire gastric epithelium (Figures S3A and S3B). Tff2-Cre; R26-NGF mice expressed a
high level of Ngf in the gastric epithelium (Figure S3C), leading
to disturbed glandular architecture and increased stromal cells
within the lamina propria (Figure 3B). Immunostaining revealed
that these stromal cells were nerves and glial cells, including
Cancer Cell 31, 21–34, January 9, 2017 23

Figure 2. ACh Signaling Stimulates NGF Production
(A) Ngf expression in cultured gastric organoids from WT and Chrm3 knockout (M3R KO) mice. Organoids were treated with carbachol at a concentration of
0, 10, or 100 mM for 7 days. n = 4/group. GAP43, growth-associated protein 43; GFAP, glial fibrillary acidic protein.
(B) Relative expression per Gapdh of neurotrophin family in MNU-treated mouse non-tumor and tumor tissues. The average expression of each gene in non-tumor
tissues is set as 1.0. n = 4/group. ND, not detected.
(C) Relative Ngf expression per Gapdh in MNU tumors isolated from mice which have taken vagotomy or sham treatment. n = 3/group.
(D) In situ hybridization of Ngf in MNU-treated non-tumor and tumor areas.
(E) Fluorescence-activated cell sorting plot of EpCAM and CD45 from MNU tumors.
(F) Relative Ngf expression per Gapdh in EpCAM+ cells and CD45+ cells isolated from WT and MNU-treated mice. n = 3/group.
Means ± SEM. *p < 0.05; ANOVA in (A), t test in (B), (C), and (F). Scale bars, 20 mm. See also Figure S2.

both adrenergic (TH+) and cholinergic (vesicular ACh transporter
[VAChT]+) neurons that expressed Dclk1 (Figures 3C, 3D, and
S3D). We also found that submucosal ganglia were larger
in NGF-overexpressing mice and indeed the number of
HuC/D+ cells in ganglia was significantly increased (Figures
S3E and S3F). In addition, Nestin+ cells were expanded within
the lamina propria and submucosal ganglia in NGF-overexpressing mice (Figures 3E and 3F). As reported previously (BelkindGerson et al., 2013; Grundmann et al., 2016), the majority of
these Nestin+ cells are positive for a glial marker S100B,
thus including glial progenitors and mature glia, but negative
for neuronal markers such as HuC/D, PGP9.5, and Dclk1, or
other stromal markers including CD31 and a-SMA (Figures
S3G–S3I). Targeting NGF overexpression to the small and large
intestine using crosses to Vil1-Cre transgenic mice increased
nerve density in these organs (Figures S3J and S3K). The expansion of stromal nerves in NGF-overexpressing mice was
suppressed by the treatment with the Trk inhibitor PLX-7486
(PLX), although the nerves rapidly re-expanded after the discontinuation of PLX treatment (Figure 3G). In contrast, the numbers
of Dclk1+ neuronal cells in ganglia did not change during this time
course, and these cells did not show any uptake of BrdU even
24 Cancer Cell 31, 21–34, January 9, 2017

after 2 months continuous administration (Figures S3L and
S3M), suggesting that the expansion of nerve fibers in NGF-overexpressing mice during adulthood occurs primarily through
axonogenesis, rather than neurogenesis.
In adult Dclk1-CreERT; R26-mTmG mice treated with tamoxifen, the recombined GFP+ nerves were initially found near the
gastric gland base. However, after 1 year, these recombined
cells gradually expanded toward the top of glands (Figures
S3N and S3O), suggesting time-dependent axonal growth
and/or nerve turnover under normal homeostasis, as shown
in other studies (Kabouridis et al., 2015). PLX treatment
suppressed this stromal lineage tracing in Dclk1-CreERT;
R26-mTmG mice (Figures S3P and S3Q), suggesting a role
for NGF in the remodeling of the stroma. Consistent with this
notion, stromal tracing in Dclk1-CreERT; R26-mTmG mice
was enhanced in MNU-induced tumors that expressed high
levels of NGF (Figure S3R). To further explore this relationship,
we co-cultured sorted Epcam Dclk1+ neurons with wild-type
(WT) or Tff2-Cre; R26-NGF gastric organoids (Figure 3H).
While cultured neurons rarely showed much neurite outgrowth
when co-cultured with WT organoids, NGF-overexpressing organoids induced significant neurite growth (Figures 3I and 3J),
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mimicking the in vivo Dclk1+ axonal growth that was dependent
on NGF.
ACh/M3R Signaling Regulates Mucosal Proliferation
and Clonal Stem Cell Expansion
To test the role of muscarinic signaling in this process, Tff2-Cre;
Chrm3flox/flox mice were used to conditionally delete the Chrm3
gene in the gastric epithelium. Loss of epithelial M3R expression
resulted in decreased proliferation following MNU-induced
injury, while there were no significant changes in proliferation
under normal conditions (Figures S4A and S4B). To examine
the effect of M3R signaling in the gastric Lgr5+ population, we
generated Lgr5-CreERT; R26-Confetti mice with or without the
Chrm3flox/flox transgene, and traced the clonal expansion of
Lgr5+ stem cells during MNU treatment. As reported previously
(Leushacke et al., 2013), multiple Lgr5+ cells began to lineage
trace each gland, with some glands showing all four of the
different fluorescent reporters, but within 2 months most glands
consolidated to a single color in a ‘‘neutral drift’’ manner. This
single-color conversion in a gland was more frequently observed
in MNU-treated mice than in non-treated mice, suggesting more
rapid loss of progenitors or faster emergence of a dominant
clone after MNU treatment (Figures 4A and 4B). However, knock
out of Chrm3 in the Lgr5+ population suppressed single-color
conversion, with the majority of glands in these mice demonstrating multi-color tracing or incomplete tracing even 2 months
after tamoxifen/MNU treatment. Thus, M3R signaling may regulate gastric epithelial proliferation and stem cell division during
mucosal regeneration.
We reported previously that ablation of Dclk1+ cells leads
to a decrease in epithelial proliferation in the intestine and
colon (Westphalen et al., 2014). We confirmed a similar
decrease in gastric proliferation following Dclk1+ cell ablation
in Dclk1-CreERT; R26-diphtheria toxin A (DTA) mice (Figures
4C and 4D). In the Dclk1-CreERT; R26-DTA model, tuft cells
were efficiently ablated after tamoxifen administration through
cell-specific expression of DTA. However, the majority of labeled
Dclk1+ nerves was not ablated and remained within the stroma,
probably because of the requirement of high levels of
Dclk1 expression for DTA-driven ablation. This provided us
with the opportunity to examine the effect of specific ablation
of tuft cells, as opposed to neurons, in these mice. We tested
the effects of a cholinergic agonist bethanechol following
ablation of Dclk1+ tuft cells, and administration of bethanechol

significantly rescued the loss of proliferation by Dclk1+ tuft cell
ablation, suggesting that the effect by tuft cell ablation in proliferation depends, at least in part, on the loss of their cholinergic
signaling.
Dclk1+ cholinergic signaling also contributed to intestinal
regeneration following DSS-colitis. While ablation of Dclk1+ cells
worsened DSS-colitis (Westphalen et al., 2014), restoration of
cholinergic signaling by bethanechol restored mucosal regeneration (Figures S4C and S4D). Furthermore, consistent with previous reports using systemic Chrm3 knockout mice (Hirota
and McKay, 2006), conditional knock out of M3R in the
colonic epithelium exacerbated the severity of DSS-colitis
(Figures S4E and S4F). Intestinal overexpression of NGF in
Vil1-Cre;R26-NGF mice with marked cholinergic innervation
improved regeneration following DSS-induced injury, whereas
simultaneous knock out of M3R blocked the NGF-mediated
regenerative effects (Figures S4E and S4F). Taken together,
these findings suggest that cholinergic signaling from tuft cells
and nerves is critical for mucosal homeostasis and regeneration.
Compared with control mice, Tff2-Cre; R26-NGF mice
showed increased proliferation within the stomach (Figures 4E
and 4F). The increased proliferation was abrogated by the
concomitant knock out of Chrm3, but unaffected by the deletion
of b2-adrenergic receptor (Adrb2), indicating that it was the
cholinergic, rather than adrenergic, neurons that were the major
drivers of epithelial proliferation in this setting (Figures 4E, 4F,
S4G, and S4H). Treatment with the Trk inhibitor PLX for 1 month
dramatically reduced the nerve density within the gastric mucosa, as well as the level of epithelial proliferation (Figure S4I).
However, the gastric epithelium returned to its baseline
hyperproliferation following removal of the Trk inhibitor. This
demonstrates that gastric ACh/NGF/Trk signaling is important
for promoting both mucosal nerve fiber growth and epithelial
proliferation.
Initiating the ACh-NGF Axis Is Sufficient to Cause
Gastric Cancer
By 8 months of age, Tff2-Cre; R26-NGF mice developed spontaneous metaplasia and dysplasia in the stomach, with an expansion of dysplastic CD44+/Ki67+ epithelial cells (Figures 5A and
S5A). By 18 months, the mice developed large gastric tumors
with intramucosal adenocarcinoma (Figure 5B). Overexpression
of NGF in colonic epithelium also induced dysplastic tumors in
the rectum (Figure S5B). These NGF-mediated effects in the

Figure 3. NGF/Trk Signaling Regulates Mucosal Innervation
(A) Gene construct of R26-LSL-Ngf-IRES-EGFP mice.
(B) H&E staining of R26-NGF and Tff2-Cre; R26-NGF mouse stomach.
(C and D) Neuron and glial marker staining (C) (red) and quantification (D) in R26-NGF and Tff2-Cre; R26-NGF (green) mice. The percentages of positive area per
total mucosal area are quantified in four images per group.
(E and F) Nes-GFP expression (E) and the cell number of GFP+ cells (F) in lamina propria (per stromal gap between two glands) and ganglia (per ganglia) in
6-week-old R26-NGF; Nes-GFP and Tff2-Cre; R26-NGF; R26-TdTomato; Nes-GFP mice. A total 20 glands and 20 ganglia was analyzed. Both NGF+ Tff2-Cre
lineage cells and Nes-GFP+ cells are colored by green.
(G) Dclk1 staining (red) of R26-NGF mice, Tff2-Cre; R26-NGF (green) mice, Tff2-Cre; R26-NGF mice treated with PLX for 1 month, and Tff2-Cre; R26-NGF mice
treated with PLX for 1 month and subsequently treated with normal diet for another 1 month.
(H–J) Co-culture experiment of sorted Dclk1+ stromal cells (red) and Tff2-Cre; R26-NGF gastric organoids (green). (H) Fluorescence-activated cell sorting plot of
Dclk1-CreERT; R26-TdTomato mouse stomach with EpCAM staining 1 day after tamoxifen induction. Cells in the left rectangular outline represent
Dclk1+ neurons, and cells in the right outline represent Dclk1+ tuft cells. (I) Day 1 and 5 neurite growth image in NGF+ organoid (green) co-culture. Arrows indicate
Dclk1+ neurons (red). (J) Quantification of length of neurite growth. The length with WT organoid co-culture is set as 1.0. n = 20/group.
Means ± SEM. *p < 0.05 (t test). DAPI, blue. Scale bars, 100 mm. See also Figure S3.
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Figure 4. ACh/M3R Signaling Regulates Mucosal Proliferation and Stem Cell Expansion
(A) Cross-sectional images of Lgr5-CreERT2; R26-Confetti mice (Chrm3WT/WT) and Lgr5-CreERT; Chrm3flox/flox; R26-Confetti mice. Mice were treated with
tamoxifen, following with or without five cycles of MNU. DAPI, white.
(B) Percentages of the glands that were fully traced by single color per total glands where recombination occurs. A total of 80 glands from four mice per group was
analyzed.
(C and D) The number of Ki67+ cells per gland (C) and Ki67 staining (D) in WT and Dclk1-CreERT; R26-DTA mice. Mice were treated with tamoxifen on day 1, and
given bethanechol for 5 days. A total of 90 glands from three mice per group was analyzed.
(E and F) Ki67 staining (E) and the number of Ki67+ cells per gland (F) in R26-NGF, Tff2-Cre; Chrm3flox/flox, Tff2-Cre; R26-NGF, and Tff2-Cre; R26-NGF;
Chrm3flox/flox mice. A total of 90 glands from three mice per group was analyzed.
Means ± SEM. *p < 0.05 (ANOVA). Scale bars, 100 mm. See also Figure S4.

stomach were attenuated by knock out of Chrm3 in gastric
epithelium (Figures S5A and S5C). Overexpression of NGF in
the Tff2-Cre; R26-NGF mice significantly accelerated tumor
growth and invasion in response to MNU (Figures 5C–5E). The
tumor-promoting effect by NGF was also evident in the
AOM-DSS colon cancer model (Figures S5D–S5F). Knock out
of Chrm3 in the gastric epithelium blocked MNU-dependent
tumor development in the setting of NGF overexpression (Figures 5C and 5E). By contrast, knock out of Adrb2 did not
suppress MNU-dependent tumor development (Figures S5G
and S5H), again establishing the role of cholinergic rather than
adrenergic nerves in gastric carcinogenesis. Ablation of
ACh-producing Dclk1+ tuft cells in the MNU model by treatment
of Dclk1-CreERT; R26-DTR mice with DT significantly inhibited
tumor development, with reduction of NGF expression and

innervation (Figures 5F, 5G, and S5I–S5K). Treatment with the
Trk inhibitor PLX prevented MNU tumor growth both in WT
and NGF-overexpressing mice, and reduced peritumoral nerve
density, CD44+ dysplastic cell expansion, and b-catenin nuclear
translocation (Figures 5H, 5I, and S5L–S5N).
We tested the effect of NGF inhibition in an allograft tumor
model (Li et al., 2014). Kras, Apc, and Tp53-mutated gastric
glands were isolated from tamoxifen-treated Lgr5-CreERT;
LSL-KrasG12D/+; LSL-p53R172H/+; Apcflox/flox mice and tumor
organoids cultured. These organoids were then implanted into
immunodeficient NOD-SCID mice, and the mice were treated
with a control or PLX7486-containing diet. After 3 weeks, tumor
size was significantly reduced by Trk inhibition, and the expansion of nerves in the peritumoral site was inhibited (Figures
S5O–S5Q). Taken together, these experiments suggest a central
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Figure 5. Initiating the ACh-NGF Axis Is Sufficient to Cause Gastric Cancer
(A) H&E (left), Ki67 (middle), and CD44 (right) staining of 8-month-old Tff2-Cre; R26-NGF mice.
(B) Gross picture and H&E staining of an 18-month-old Tff2-Cre; R26-NGF mouse stomach. Arrow indicates tumor.
(C–E) MNU-induced tumors in R26-NGF (n = 19), Tff2-Cre; R26-NGF (n = 16), and Tff2-Cre; R26-NGF; Chrm3flox/flox (n = 6) mice. Mice were euthanized at
48 weeks after the beginning of MNU. Gross picture (C), H&E image (D), and tumor area (cm2) (E) are shown. Arrows indicate tumors.
(F and G) MNU-treated Dclk1-CreERT; R26-DTR mice were treated with vehicle (n = 7) or DT (10 mg/kg, n = 13). Vehicle or DT and tamoxifen were given once a
week from 28 to 52 weeks after the beginning of MNU, then mice were euthanized. Representative tumor image (F) and tumor area (G) are shown.
(H and I) Gross images (H) and tumor area (I) of MNU-treated R26-NGF and Tff2-Cre; R26-NGF mice with or without PLX treatment. PLX was given from 24 to
36 weeks after the beginning of MNU, then mice were sacrificed. n = 4/group. Average tumor area is indicated by black bars.
Means ± SEM. *p < 0.05; ANOVA in (E), t test in (G) and (I). Scale bars, 100 mm in (A), (B) (right), and (D), 5 mm in (B) (left), (C), (F), and (H). See also Figure S5.

role for NGF/Trk signaling, mediated through a cholinergic niche,
in the initiation and progression of stomach cancer.
M3R Signaling Regulates Apc-Dependent Tumor Growth
through YAP Activation
We recently reported that Mist1+ stem cells in the oxyntic glands
of the proximal stomach that express Bhlha15 gene (also known
28 Cancer Cell 31, 21–34, January 9, 2017

as Mist1) can give rise to gastric cancer (Hayakawa et al., 2015a).
In Mist1-CreERT; R26-Tomato mice, we also found robust lineage tracing in the distal stomach (Figure S6A), suggesting the
fair and broad expression of Mist1 in the gastric antrum. Interestingly, loss of Apc gene in the Mist1 lineage was not sufficient to
create tumors in the proximal corpus, as reported previously
(Hayakawa et al., 2015a, 2016); however, Apc deletion in the

Mist1 lineage did induce rapid macroscopic tumors in the gastric
antrum (Figure S6B).
Using this mouse model of antral gastric tumor, we generated
Mist1-CreERT; Apcflox/flox; Chrm3flox/flox mice to explore the role
of M3R signaling in Apc/b-catenin-dependent tumor growth. In
keeping with the role of the cholinergic signaling described
above, we also found a significant reduction in tumor burden
with loss of just one copy of Chrm3 gene, and hemizygous
Chrm3-floxed mice showed an almost complete absence of
macroscopic tumor development (Figures 6A–6C). NGF expression and nerve density were significantly decreased in Apc and
Chrm3 double knockout mice, supporting the role of cholinergic
signaling on NGF-mediated innervation (Figures 6D, 6E, S6C,
and S6D). Nevertheless, immunostaining showed strong b-catenin nuclear accumulation both in Chrm3-WT and Chrm3-null
stomachs (Figure S6E), suggesting that knock out of M3R
suppresses tumor growth downstream of b-catenin nuclear
translocation, possibly by inhibiting TCF transcriptional activity.
YAP modulates Wnt/b-catenin signaling as a transcriptional
coactivator, and is required for intestinal tumor growth following
the loss of Apc (Azzolin et al., 2014; Rosenbluh et al., 2012). While
YAP is minimally expressed in normal gastric epithelium or
cultured organoids, strong YAP upregulation is observed in
dysplastic tissues or organoids after Apc deletion (Figures 6F,
S6F, and S6G). However, YAP was rarely upregulated within
the Chrm3-null gastric dysplasia, even though they showed
strong b-catenin expression (Figures 6F and 6G). A gene
downstream of YAP, BCL2L1, was also downregulated in the
Chrm3-null gastric dysplasia compared with the Chrm3-WT
mice (Figure S6H). The Wnt target genes, Sox9 and CD44, were
prominently expressed in Chrm3-WT, nuclear b-catenin+
dysplastic cells, but not in the Chrm3-null, b-catenin+ cells (Figures S6I and S6J). Furthermore, we revisited our previous microarray data (GEO: GSE30295) which compared gene expression between gastric tumors isolated from the vagotomized
anterior stomach and the non-vagotomized posterior stomach
in a hypergastrinemic mouse model (Zhao et al., 2014). We found
downregulation of YAP-associated genes along with upregulation of YAP inhibitory genes in the vagotomized anterior stomach,
suggesting that the inhibition of ACh signaling by vagotomy can
block YAP activity in this model (Figure 6H). Thus, M3R signaling
may regulate tumor growth in mice by controlling YAP activity.
The M3R, a G-protein-coupled receptor (GPCR), selectively
couples to G-proteins of the Gq/11 family, and it has been suggested that GPCRs regulate YAP activation by controlling large
tumor suppressor kinase activity (Feng et al., 2014; Yu et al.,
2012, 2014). In the TMK1 gastric cancer cell line which expresses the M3R (Kodaira et al., 1999), treatment with carbachol
reduced the level of phosphorylated YAP, with no significant
changes in the levels of total YAP (Figure 7A). Similarly, carbachol treatment in Apc-deleted gastric organoids reduced the
level of phosphorylated YAP (Figure S6G). However, treatment
with a Gq/11-specific inhibitor YM254890 blocked the changes
of YAP phosphorylation in TMK1 cells after carbachol stimulation, suggesting that cholinergic stimuli dephosphorylates
YAP indeed through a Gq/11 family protein. We next transfected
a human M3R gene-expressing construct into the M3R-negative
AGS cell line. Overexpression of M3R decreased the level of
phosphorylated YAP in a Gq-dependent manner, and activated

the transcriptional activity of YAP in a luciferase assay (Dupont
et al., 2011) (Figures 7B, 7C, and S7A). YAP target genes
including AREG, BIRC5, and BCL2L1 were significantly upregulated by M3R overexpression (Figure 7D). Consistent with the
findings in our mouse models, carbachol treatment or M3R
overexpression significantly upregulated NGF expression in
human cancer cells, although NGF treatment did not cause
YAP activation contrary to carbachol (Figures S7B and S7C).
We investigated NGF expression levels in 16 gastric cancer
cell lines (Figures S7D and S7E), and confirmed NGF mRNA
expression in 10 lines (62.5%), and NGF protein expression in
9 lines (56.3%). Staining of 36 human gastric cancer samples
with NGF antibody demonstrated that NGF was moderately
expressed in 63.9% of cancer patients and strongly expressed
in 5.6% patients, while non-dysplastic stomach does not express NGF or YAP (Figures 7E–7G, S7F, and S7G). Importantly,
there was a significant correlation between YAP immunoreactivity and NGF or ChAT immunoreactivity. In addition, we evaluated NGF and YAP expression in an additional set of 97 human
gastric cancer samples, and correlated expression with clinical
and histopathological data. In this additional cohort, NGF was
expressed in 53.6% of cancer cases. NGF expression was
significantly associated with a higher cancer stage (adjusted
odds ratio [AOR] of 4.57), and expression was more evident in intestinal-type cancers than in diffuse-type cancers (Figures 7H
and 7I and Table S1). YAP expression was also significantly
associated with cancer stage (AOR of 5.71), as well as an
increased risk of lymphoid node metastasis (AOR of 6.55) (Table
S2). Taken together, these results support the significance of the
NGF-ACh-YAP axis in human gastric cancers, particularly in
advanced, intestinal-type cancers.
DISCUSSION
We found that Dclk1 and ChAT are co-expressed in both tuft
cells and nerves within the stomach and intestine, and that
both cholinergic sources expand at discrete times during carcinogenesis. Tuft cells are dramatically expanded in early carcinogenesis, particularly in inflammation-associated cancer models.
Previous studies suggested that tuft cells could potentially influence carcinogenesis through production of inflammatory mediators (Bailey et al., 2014; Okumura et al., 2010; Quante et al.,
2012), but here we have shown that tuft cells are also a local
source of ACh that contributes to early cancer growth and remodeling of the peritumoral neural microenvironment.
We have proposed that the ACh-NGF-positive feedback loop
is the basis for the abnormal innervation observed in the tumor
microenvironment. Previous studies have reported that NGF
can be induced by cholinergic stimuli (da Penha Berzaghi
et al., 1993; Lapchak et al., 1993; Mahmoud et al., 2015), and
in turn NGF can promote cholinergic nerve growth (Collins,
1984; Collins and Dawson, 1983; Kniewallner et al., 2014),
consistent with our results. While the major receptor for NGF is
TrkA, another neurotrophin receptor p75NTR can bind to NGF
and pro-NGF (Howard et al., 2013). Given the significant effects
by the Trk inhibitor in our study, it appears that Trk is the primary
receptor within the ACh-NGF axis. Many clinical studies have
investigated the efficacy of Trk inhibitors in cancers with mitogenic Trk-fused mutations (Vaishnavi et al., 2015). Furthermore,
Cancer Cell 31, 21–34, January 9, 2017 29

0.5

F

*

0.0008
0.0006
0.0004
0.0002
0

Chrm3
(n = 6)

Chrm3
(n = 5)

Chrm3WT/WT
(n = 8)

0

E
0.001

Chrm3WT/WT

H

Chrm3

G

*

YAP+ cells in 100 of
-catenin+ cells

100

Chrm3WT/WT

1

Chrm3

80
60
40
20

Chrm3

*

Chrm3WT/WT

Chrm3

D

*

1.5

B

Chrm3

Chrm3WT/WT

C

Tumor area(cm2)

Chrm3

Chrm3WT/WT

Relative Ngf expression / Gapdh

A

Senp2
Bcl9
Lrp6
Ccnd3
Porcn
Rhou
Ctbp1
Tcf7
Axin1
Fzd4
Fzd1
Btrc
Wif1
Frzb
Gli2
Fzd6
Frat1;
Dvl2
Sfrp4
Wnt4
Fzd3
Foxn1
Wnt3a
Wnt7b
Dixdc1
Wnt8a
Hipk2
Tle2
Wnt10a
Wnt9a
Fgf4
Wnt16
Lef1
Wwc1
Lpp
Taz
Wnt2
Llgl1
Fshb
Rassf2
Bcl2l1
Tjp3
Tgfbrap1
Dchs1
Mgdc
Birc5
Smad3
Fat1
Bmpr1a
Ywhaz
Yap1
Tead4
Csnk1d
Tcf25
Smad1
Limd1
Ywhae
Parp6
Ndrg3
Crb3
Gsk3b

YAP and its associated genes

Stk4
Ctgf
Mpp5
STK3
Mobkl2a
Sav1
Dkk1

YAP inhibitory genes

0
Chrm3WT/WT

Ppp2r1a
Kremen1

Chrm3
-1.50

-1.00

-0.50

0.00

0.50

1.00

1.50

Log2 Fold Change
Figure 6. M3R Signaling Regulates Apc-Dependent Tumor Growth through YAP Activation
(A–C) Gross pictures (A) and H&E images (B) of Mist1-CreERT; Apcflox/flox, Mist1-CreERT; Apcflox/flox; Chrm3flox/WT, and Mist1-CreERT; Apcflox/flox; Chrm3flox/flox
mouse tumors. Lines indicate tumor area. Tumor area (cm2) is quantified in (C). Average tumor area is indicated by black bars.
(D–G) Ngf gene expression per Gapdh (D) (n = 3) and immunofluorescence of NGF (E) (red) and double staining (F) of YAP (red) and b-catenin (green) in
Mist1-CreERT; Apcflox/flox and Mist1-CreERT; Apcflox/flox; Chrm3flox/flox mice. Right panels in (F) are enlarged images of white box area in left panels. Numbers of
YAP+ cells in 100 nuclear b-catenin+ cells are shown in (G). A total of 500 nuclear b-catenin+ cells per group was analyzed.
(H) Fold changes of YAP-related gene expression in mouse gastric tumor on the vagotomized side compared with tumor on the non-vagotomized side.
Means ± SEM. *p < 0.05; ANOVA in (C), t test in (D) and (G). DAPI, blue. Scale bars, 100 mm (B), (E), and (F), 5 mm (A). See also Figure S6.
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Figure 7. M3R Activates YAP Signaling in Human Gastric Cancer Cells
(A) Immunoblotting of TMK-1 cells treated with 1 mM carbachol for the indicated times. Cells were pretreated with vehicle or 10 mM YM254890. b-Actin was used
as a loading control.
(B–D) Relative YAP luciferase activity (B) (n = 3/group), immunoblotting (C), and relative gene expression (D) (n = 3/group) in AGS cells transfected with the
indicated amount of control or M3R-expressing vectors. Samples are collected 24 hr after transfection.
(E) Representative images of YAP, NGF, and ChAT staining in human gastric cancers.
(F and G) Correlation between the expression levels of YAP and NGF (F), and of YAP and ChAT (G) in 36 gastric cancer cases.
(H and I) NGF positivity in different cancer stages (H) and histological forms (I) in 97 gastric cancer cases. Means ± SEM. *p < 0.05; t test in (B) and (D), Fisher’s test
in (F) and (G). Scale bars, 200 mm. See also Figure S7, Tables S1 and S2.
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anti-NGF antibody has been used in several clinical studies for
testing its effect on pain management in osteoarthritis patients
(Bannwarth and Kostine, 2014). Our preclinical results suggest
that Trk inhibitors and anti-NGF antibody may be effective for
the therapy for stomach cancer by targeting the ACh-NGF axis.
The muscarinic ACh receptors are classified into five
distinct subtypes; gastric epithelial cells primarily express
M3R, and also low level of muscarinic ACh receptor-1 (M1R)
and receptor-5 (M5R) (Aihara et al., 2005; Zhao et al., 2014).
The activation of M3R leads to a variety of biochemical and
electrophysiological responses, and the resulting physiological
effects may depend on the cell types. It has been suggested
that M3R can activate mitogen-activated protein kinase (Kodaira
et al., 1999), Akt (Song et al., 2007), or RhoA (Belo et al., 2011)
and contribute to tumor growth in various cancers. We and
others reported that M3R activates the Wnt pathway, and our
current study suggests that M3R-mediated Wnt activation may
be through YAP, a downstream target of M3R.
YAP, a downstream effector of the Hippo pathway, regulates
various cellular functions such as proliferation, survival, stemness, or pluripotency. YAP is upregulated and activated by
loss of Apc, and in turn YAP activation is required for
b-catenin-dependent cancer growth (Azzolin et al., 2014; Cai
et al., 2015; Rosenbluh et al., 2012). Accordingly, YAP controls
tissue regeneration and tumorigenesis in various organs
including stomach, by activating tissue stem cells (Gregorieff
et al., 2015; Imajo et al., 2015; Jiao et al., 2014). GPCRs that
activate G12/13, Gq/11, or Gi/o, can activate YAP by repressing
YAP phosphorylation, while GPCRs that mainly activate Gs
signaling such as Adrb2, are able to induce YAP phosphorylation
and subsequent YAP inhibition (Yu et al., 2012). Our data
suggest that the M3R can activate YAP signaling in a manner
similar to other Gq/11 family receptors. Thus, destruction of
the Apc complex is only able to induce full activation of Wnt
targets and aggressive tumor development when there is
sufficient, permissive cholinergic signaling through the M3R.
Although it seems that M3R regulates YAP activity predominantly through its dephosphorylation, the involvement
of M3R in YAP upregulation during initial malignant transformation remains uncertain, and thus needs to be elucidated in
future studies.
In summary, we elucidated the machinery of nerve-epithelial
interaction within the stomach, including the source of ACh,
the cause of abnormal innervations in cancer, and the regulation
of the Wnt and YAP pathways by M3R signaling, constituting
what we term the ACh-NGF-YAP axis. Inhibition of ACh,
M3R, or NGF may be important future therapeutic strategies to
consider in the treatment of gastrointestinal cancers.

as follows: the R26-LSL-Ngf-IRES-GFP alleles were generated by inserting
CAG–loxP-STOP-LoxP-Ngf-IRES-GFP-poly(A) cassettes into a Rosaacceptor targeting plasmid (CTV plasmid, a gift from Dr. Klaus Rajewsky
[Addgene no. 15912]). Mouse lines where generated by homologous
recombination in KV1 (129S6/SvEvTac x C57BL/6J) embryonic stem cells
followed by injection into C57BL/6J blastocysts. Chimeras were bred for
germline transmission. Mice were backcrossed to C57BL/6J background
for at least six generations. Cre recombinase was activated in CreERT
mouse lines by oral administration of TAM (3 mg/0.2 mL corn oil). All
animal studies and procedures were approved by the ethics committees
at Columbia University and the University of Tokyo. All protocols using
human materials were approved by the ethics committees at Columbia
University and Gifu University, and written informed consent was obtained
from all patients.
Treatment
MNU (Sigma) were prepared as described previously, and mice (8-weekold) were given drinking water containing 240 ppm MNU on alternate
weeks for a total of 10 weeks (total exposure of 5 weeks) (Hayakawa
et al., 2015b). For tumor analysis, mice were analyzed 36–52 weeks after
the beginning of MNU, as indicated. For Dclk1+ cell ablation in Dclk1CreERT; R26-DTR mice, tamoxifen and DT (10 mg/kg) were administered
once a week. PLX-7486, provided from Plexxicon, has been used in
Phase I clinical studies and detailed information is available on the
NCI drug dictionary: http://www.cancer.gov/publications/dictionaries/cancerdrug?cdrid=747694. PLX-7486 was mixed into the AIN-76A mouse chow
(100 mg/kg), and fed for the indicated periods. The control group was given
AIN-76A chow without PLX-7486. Bethanechol was dissolved in drinking
water at a concentration of 800 mg/L. DSS was dissolved in drinking water at
3% and given for 5 days. Vagotomy was performed as described previously
(Zhao et al., 2014).
Statistical Analysis
The differences between the means were compared using the Student’s
t test (two-tailed). One-way ANOVA with post hoc test was performed for
multiple comparisons. Fisher’s exact test was used to determine if
there are nonrandom associations between two categorical variables.
In Tables S1 and S2, a logistic regression analysis was conducted to evaluate the odds ratios as an estimate of whether NGF and YAP expression
(‘‘Positive’’ includes [+] and [++] cases) was associated with each parameters. p values of <0.05 were considered to indicate statistical significance.
All statistical analyses were performed using the JMP (v.11) and the
SAS (v.9.4) software.
ACCESSION NUMBERS
Microarray data which compared gene expression between gastric tumors
isolated from the vagotomized anterior stomach and the non-vagotomized
posterior stomach in hypergastrinemic mice were deposited in GEO database
(GEO: GSE30295).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and two tables and can be found with this article online at
http://dx.doi.org/10.1016/j.ccell.2016.11.005.

EXPERIMENTAL PROCEDURES
AUTHOR CONTRIBUTIONS
Mice
Mist1-CreERT2 (Shi et al., 2009), Dclk1-CreERT (Westphalen et al., 2014),
Tff2-Cre (Dubeykovskaya et al., 2016), Chrm3flox (Gautam et al., 2006),
Chrm3 knockout (Aihara et al., 2003), Adrb2flox (Hinoi et al., 2008), and NesGFP (Mignone et al., 2004) mice were described previously. Apcflox mice
were obtained from the National Cancer Institute. Lgr5-CreERT-IRESEGFP, Vil1-Cre, Chat-GFP, NOD-SCID, Adrb2 knockout, R26-mTmG,
R26-TdTomato, R26-Confetti, R26-DTR, and R26-DTA mice were purchased
from the Jackson Laboratory. R26-LSL-Ngf-IRES-EGFP mice were generated
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